Different activation treatments for successful development of bovine oocytes following intracytoplasmic sperm injection.
In this study, the developmental capacity and cytogenetic composition of different oocyte activation protocols was evaluated following intracytoplasmic sperm injection (ICSI) of in vitro matured bovine oocytes. Motile spermatozoa selected by Percoll density gradient were treated with 5 mM dithiothreitol (DTT) and analysed for ultrastructural changes of the head using transmission electron microscopy (TEM). The alterations in sperm morphology after DTT treatment for different times (15, 30 and 60 min) were 10%, 45-55% and 70-85%, respectively. Further, a partial decondensation of sperm heads was observed after DTT treatment for 30 min. Oocytes were injected with sperm treated with DTT for 30 min. In group 1, sperm injection was performed without any activation stimulus to the oocytes. In group 2, sham injection without sperm was performed without activating the oocytes. Oocytes injected with sperm exposed to 5 microM ionomycin for 5 min (group 3), 5 microM ionomycin + 1.9 mM dimethylaminopurine (DMAP) for 3 h (group 4) and 5 microM ionomycin + 3 h culture in M199 + 1.9 mM DMAP (group 5) were also evaluated for cleavage, development and chromosomal abnormality. Cleavage and development rates in groups 1, 2 and 3 were significantly (p < 0.05) lower than those in groups 4 and 5. The incidence of chromosomal abnormality in the embryos treated directly with DMAP after ionomycin (group 4) was higher than in group 5. We conclude that immediate DMAP treatment after ionomycin exposure of oocytes results in arrest of release of the second polar body, and thus leads to changes in chromosomal pattern. Therefore, the time interval between ionomycin and DMAP plays a crucial role in bovine ICSI.
Ock
S A
SA
Gyeongsang National University, Republic of Korea and Madras Veterinary College, Tamil Nadu, India.
Bhak
J S
JS
Balasubramanian
S
S
Lee
H J
HJ
Choe
S Y
SY
Rho
G J
GJ
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D002417:Cattle; D004229:Dithiothreitol / Q000494:pharmacology; D005260:Female; D015759:Ionomycin / Q000494:pharmacology; D007476:Ionophores / Q000494:pharmacology; D008297:Male; D009865:Oocytes / Q000187:drug effects / Q000502:physiology*; D011725:Pyridines / Q000494:pharmacology; D020554:Sperm Injections, Intracytoplasmic / Q000379:methods*; D013997:Time Factors
C417980:4-(dimethylamine)pyridine; D000975:Antioxidants; D007476:Ionophores; D011725:Pyridines; D015759:Ionomycin; D004229:Dithiothreitol